MedPage Today on MSN
Time of Day Matters for Immunochemotherapy in Lung Cancer
This is a "landmark study" for cancer immunotherapy and circadian medicine, researcher say ...
Scientists in Australia have mapped the "neighbourhoods" of lung cancer cells and found that cell metabolism plays a key role ...
University of Queensland researchers who mapped cancer cell "neighborhoods" in the most common type of lung cancer have found ...
Survivors of non-small cell lung cancer are at risk for both second primary lung cancers as well as non-lung secondary ...
Lung cancer cases are rising among non-smokers. Here's why the proportion is increasing, key causes, early signs, diagnosis, ...
Scientists in Australia have uncovered how the metabolic behaviour of lung cancer cells plays a decisive role in determining ...
When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer ...
SurvivorNet on MSN
Could timing give your cancer treatment a boost? New study on the best time to receive immunotherapy & chemo for non-small cell lung cancer
A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...
The FDA accepted an application for ivonescimab with chemotherapy for patients with lung cancer driven by EGFR changes after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results